Symbols / MLTX Stock $17.13 -0.52% MoonLake Immunotherapeutics

Healthcare • Biotechnology • Switzerland • NCM
MLTX (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

MoonLake Immunotherapeutics, a clinical-stage biotechnology company, focuses on developing therapies for inflammatory skin and joint diseases. It develops Sonelokimab, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody for the treatment of inflammatory diseases in dermatology and rheumatology, as well as for hidradenitis suppurativa, psoriatic arthritis, axial spondyloarthritis, palmoplantar pustulosis, and psoriasis. The company was founded in 2021 and is headquartered in Zug, Switzerland.

Stock Fundamentals
Scroll to Statements
Market Cap 1.25B Enterprise Value 916.89M Income -227.32M Sales — Book/sh 4.27 Cash/sh 5.49
Dividend Yield — Payout 0.00% Employees 130 IPO — P/E — Forward P/E -4.73
PEG — P/S — P/B 4.02 P/C — EV/EBITDA -3.79 EV/Sales —
Quick Ratio 8.77 Current Ratio 9.27 Debt/Eq 24.86 LT Debt/Eq — EPS (ttm) -3.53 EPS next Y -3.62
EPS Growth — Revenue Growth — Earnings 2026-05-11 ROA -33.92% ROE -60.78% ROIC —
Gross Margin 0.00% Oper. Margin 0.00% Profit Margin 0.00% Shs Outstand 72.85M Shs Float 39.47M Short Float 21.23%
Short Ratio 8.45 Short Interest — 52W High 62.75 52W Low 5.95 Beta 1.19 Avg Volume 1.19M
Volume 81.70K Target Price $26.71 Recom Buy Prev Close $17.22 Price $17.13 Change -0.52%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$26.71
Mean price target
2. Current target
$17.13
Latest analyst target
3. DCF / Fair value
$-29.74
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$17.13
Low
$6.00
High
$40.00
Mean
$26.71

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-03-30 reit BTIG Buy → Buy $30
2026-03-23 up Wolfe Research Underperform → Outperform $24
2026-03-19 up Rothschild & Co Neutral → Buy $40
2026-03-11 main Clear Street Buy → Buy $70
2026-03-02 main RBC Capital Sector Perform → Sector Perform $13
2026-03-02 main HC Wainwright & Co. Buy → Buy $40
2026-02-26 reit Needham Buy → Buy $25
2026-02-24 main Oppenheimer Outperform → Outperform $35
2026-02-23 main BTIG Buy → Buy $30
2026-02-23 main Needham Buy → Buy $25
2026-02-20 main RBC Capital Sector Perform → Sector Perform $12
2026-02-09 reit BTIG Buy → Buy $24
2026-02-03 reit HC Wainwright & Co. Buy → Buy $32
2026-01-15 down Goldman Sachs Neutral → Sell $10
2026-01-09 reit HC Wainwright & Co. Buy → Buy $32
2026-01-09 up BTIG Neutral → Buy $24
2025-11-21 main HC Wainwright & Co. Buy → Buy $26
2025-11-03 up HC Wainwright & Co. Neutral → Buy $30
2025-10-29 down Citigroup Neutral → Sell $5
2025-10-02 down HC Wainwright & Co. Buy → Neutral —
News
RSS: Latest MLTX news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-04-14 BODENSTEDT MATTHIAS Chief Financial Officer — 2,426 $19.56 $47,453
2026-04-13 SANTOS DA SILVA JORGE Chief Executive Officer — 150,000 $18.23 $2,752,163
2026-04-10 BODENSTEDT MATTHIAS Chief Financial Officer — 87,795 $18.94 $1,663,935
2026-03-31 BVF PARTNERS L P Beneficial Owner of more than 10% of a Class of Security — 3,750,000 $16.79 $62,962,500
2026-01-07 BODENSTEDT MATTHIAS Chief Financial Officer — 354,296 $0.00 $0
2025-12-19 SANTOS DA SILVA JORGE Chief Executive Officer — 196,316 — —
2025-12-19 BODENSTEDT MATTHIAS Chief Financial Officer — 294,473 — —
2025-12-19 REICH KRISTIAN Officer — 35,389 — —
2025-12-09 SANTOS DA SILVA JORGE Chief Executive Officer — 200,000 $14.49 $2,974,700
2025-12-09 REICH KRISTIAN Officer — 202,908 $14.43 $3,012,462
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.00
0.00
0.00
0.00
Operating Revenue
0.00
0.00
0.00
0.00
Operating Expense
244.83
+71.10%
143.09
+164.38%
54.12
-16.81%
65.06
Research And Development
202.86
+79.89%
112.77
+254.60%
31.80
-24.37%
42.05
Selling General And Administration
41.97
+38.43%
30.32
+35.84%
22.32
-3.00%
23.01
General And Administrative Expense
41.97
+38.43%
30.32
+35.84%
22.32
-3.00%
23.01
Other Gand A
41.97
+38.43%
30.32
+35.84%
22.32
-3.00%
23.01
Total Expenses
244.83
+71.10%
143.09
+164.38%
54.12
-16.81%
65.06
Operating Income
-244.83
-71.10%
-143.09
-164.38%
-54.12
+16.81%
-65.06
Total Operating Income As Reported
-244.83
-71.10%
-143.09
-164.38%
-54.12
+16.81%
-65.06
EBITDA
-219.85
-83.85%
-119.58
-174.16%
-43.62
+32.79%
-64.90
Normalized EBITDA
-219.85
-83.85%
-119.58
-174.16%
-43.62
+32.79%
-64.90
Reconciled Depreciation
2.62
+88.88%
1.39
+274.32%
0.37
+124.54%
0.16
EBIT
-222.46
-83.91%
-120.96
-175.01%
-43.98
+32.39%
-65.06
Net Income
-227.32
-91.13%
-118.94
-230.31%
-36.01
+27.95%
-49.97
Pretax Income
-229.71
-89.90%
-120.96
-175.01%
-43.98
+31.77%
-64.47
Net Non Operating Interest Income Expense
-7.25
0.00
0.00
—
Interest Expense Non Operating
7.25
0.00
0.00
—
Net Interest Income
-7.25
0.00
0.00
—
Interest Expense
7.25
0.00
0.00
—
Other Income Expense
22.37
+1.10%
22.13
+118.28%
10.14
+1613.28%
0.59
Other Non Operating Income Expenses
22.37
+1.10%
22.13
+118.28%
10.14
+1613.28%
0.59
Tax Provision
0.61
+116.67%
0.28
+200.00%
0.09
+158.48%
0.04
Tax Rate For Calcs
0.00
+0.00%
0.00
+0.00%
0.00
+0.00%
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-230.32
-89.96%
-121.24
-175.06%
-44.08
+31.67%
-64.51
Net Income From Continuing Operation Net Minority Interest
-227.32
-91.13%
-118.94
-230.31%
-36.01
+27.95%
-49.97
Net Income From Continuing And Discontinued Operation
-227.32
-91.13%
-118.94
-230.31%
-36.01
+27.95%
-49.97
Net Income Continuous Operations
-230.32
-89.96%
-121.24
-175.06%
-44.08
+31.67%
-64.51
Minority Interests
3.00
+30.11%
2.31
-71.41%
8.07
-44.46%
14.53
Normalized Income
-227.32
-91.13%
-118.94
-230.31%
-36.01
+27.95%
-49.97
Net Income Common Stockholders
-227.32
-91.13%
-118.94
-230.31%
-36.01
+27.95%
-49.97
Diluted EPS
-3.53
-86.77%
-1.89
-158.90%
-0.73
+43.06%
-1.28
Basic EPS
-3.53
-86.77%
-1.89
-158.90%
-0.73
+43.06%
-1.28
Basic Average Shares
64.46
+2.53%
62.87
+27.99%
49.12
+26.03%
38.98
Diluted Average Shares
64.46
+2.53%
62.87
+27.99%
49.12
+26.03%
38.98
Diluted NI Availto Com Stockholders
-227.32
-91.13%
-118.94
-230.31%
-36.01
+27.95%
-49.97
Line Item Trend 2023-12-31
Total Assets
526.54
Current Assets
514.17
Cash Cash Equivalents And Short Term Investments
511.01
Cash And Cash Equivalents
451.17
Cash Financial
—
Other Short Term Investments
59.84
Receivables
1.06
Other Receivables
1.06
Prepaid Assets
2.10
Total Non Current Assets
12.37
Net PPE
3.95
Gross PPE
3.95
Properties
0.00
Buildings And Improvements
3.63
Other Properties
0.32
Non Current Prepaid Assets
8.42
Other Non Current Assets
—
Total Liabilities Net Minority Interest
13.05
Current Liabilities
9.97
Payables And Accrued Expenses
5.99
Payables
2.21
Accounts Payable
1.46
Other Payable
0.37
Current Accrued Expenses
3.78
Employee Benefits
0.58
Pensionand Other Post Retirement Benefit Plans Current
2.78
Total Tax Payable
0.37
Current Debt And Capital Lease Obligation
1.20
Current Debt
—
Other Current Borrowings
—
Current Capital Lease Obligation
1.20
Total Non Current Liabilities Net Minority Interest
3.08
Long Term Debt And Capital Lease Obligation
2.50
Long Term Debt
—
Long Term Capital Lease Obligation
2.50
Non Current Pension And Other Postretirement Benefit Plans
0.58
Stockholders Equity
495.68
Common Stock Equity
495.68
Capital Stock
0.01
Common Stock
0.01
Preferred Stock
0.00
Share Issued
60.47
Ordinary Shares Number
60.47
Treasury Shares Number
0.00
Additional Paid In Capital
609.97
Retained Earnings
-116.66
Gains Losses Not Affecting Retained Earnings
2.36
Treasury Stock
—
Minority Interest
17.82
Other Equity Adjustments
2.36
Total Equity Gross Minority Interest
513.49
Total Capitalization
495.68
Working Capital
504.20
Invested Capital
495.68
Total Debt
3.70
Net Debt
—
Capital Lease Obligations
3.70
Net Tangible Assets
495.68
Tangible Book Value
495.68
Preferred Stock Equity
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-196.01
-68.12%
-116.59
-172.54%
-42.78
+23.47%
-55.89
Cash Flow From Continuing Operating Activities
-196.01
-68.12%
-116.59
-172.54%
-42.78
+23.47%
-55.89
Net Income From Continuing Operations
-230.32
-89.96%
-121.24
-175.06%
-44.08
+31.67%
-64.51
Depreciation Amortization Depletion
2.62
+88.88%
1.39
+274.32%
0.37
+124.54%
0.16
Depreciation
—
—
0.01
+6.47%
0.01
Depreciation And Amortization
2.62
+88.88%
1.39
+274.32%
0.37
+124.54%
0.16
Other Non Cash Items
-1.02
-349.34%
-0.23
-277.34%
0.13
+86.99%
0.07
Pension And Employee Benefit Expense
-0.06
-5900.00%
0.00
+101.18%
-0.09
-127.96%
0.30
Stock Based Compensation
12.90
+77.12%
7.28
+2.48%
7.11
-26.40%
9.65
Operating Gains Losses
-0.06
-5900.00%
0.00
+101.18%
-0.09
-127.96%
0.30
Change In Working Capital
19.88
+625.32%
-3.78
+39.14%
-6.22
-293.57%
-1.58
Change In Receivables
-2.02
-13.38%
-1.79
-112.62%
-0.84
-1128.88%
-0.07
Change In Prepaid Assets
0.56
+104.35%
-12.89
-103.17%
-6.35
-132.42%
-2.73
Change In Payables And Accrued Expense
23.15
+87.85%
12.32
+881.21%
1.26
-8.41%
1.37
Change In Accrued Expense
2.59
-49.87%
5.17
+1680.73%
-0.33
-112.18%
2.69
Change In Payable
20.56
+187.35%
7.16
+351.99%
1.58
+220.44%
-1.31
Change In Other Working Capital
—
—
-0.07
—
Change In Other Current Assets
-0.59
-9683.33%
-0.01
+90.91%
-0.07
0.00
Change In Other Current Liabilities
-1.22
+14.13%
-1.42
-540.99%
-0.22
-45.65%
-0.15
Investing Cash Flow
202.99
+198.73%
-205.60
-716.38%
-25.18
+22.13%
-32.34
Cash Flow From Continuing Investing Activities
202.99
+198.73%
-205.60
-716.38%
-25.18
+22.13%
-32.34
Net PPE Purchase And Sale
-0.04
+93.27%
-0.52
-83.10%
-0.28
-1674.00%
-0.02
Purchase Of PPE
-0.04
+93.27%
-0.52
-83.10%
-0.28
-1674.00%
-0.02
Capital Expenditure
-0.04
+93.27%
-0.52
-83.10%
-0.28
-1674.00%
-0.02
Net Investment Purchase And Sale
203.03
+199.00%
-205.08
-723.60%
-24.90
+22.97%
-32.32
Purchase Of Investment
-265.37
+24.24%
-350.28
-99.32%
-175.73
-316.17%
-42.23
Sale Of Investment
468.40
+222.58%
145.20
-3.73%
150.83
+1423.34%
9.90
Financing Cash Flow
146.00
+184.53%
51.31
-89.30%
479.70
+300.78%
119.69
Cash Flow From Continuing Financing Activities
146.00
+184.53%
51.31
-89.30%
479.70
+300.78%
119.69
Net Issuance Payments Of Debt
73.02
0.00
0.00
+100.00%
-15.00
Issuance Of Debt
73.02
0.00
0.00
0.00
Repayment Of Debt
—
0.00
0.00
+100.00%
-15.00
Long Term Debt Issuance
73.02
0.00
0.00
—
Long Term Debt Payments
—
0.00
0.00
+100.00%
-15.00
Net Long Term Debt Issuance
73.02
0.00
0.00
+100.00%
-15.00
Short Term Debt Issuance
—
—
—
0.00
Net Short Term Debt Issuance
—
—
—
0.00
Net Common Stock Issuance
72.39
+37.79%
52.54
-89.11%
482.45
0.00
Common Stock Payments
—
-0.00
0.00
0.00
Repurchase Of Capital Stock
—
-0.00
0.00
0.00
Proceeds From Stock Option Exercised
0.58
+139.67%
0.24
0.00
-100.00%
0.00
Net Other Financing Charges
—
-1.47
+46.60%
-2.75
-102.04%
134.69
Changes In Cash
152.98
+156.48%
-270.87
-165.79%
411.74
+1208.84%
31.46
Effect Of Exchange Rate Changes
1.11
+766.41%
0.13
+268.42%
-0.08
-989.93%
0.01
Beginning Cash Position
180.43
-60.01%
451.17
+1042.03%
39.51
+391.44%
8.04
End Cash Position
334.52
+85.40%
180.43
-60.01%
451.17
+1042.04%
39.51
Free Cash Flow
-196.04
-67.40%
-117.11
-171.95%
-43.06
+22.98%
-55.91
Interest Paid Supplemental Data
5.06
0.00
0.00
—
Income Tax Paid Supplemental Data
—
0.15
+253.11%
0.04
+867.37%
0.00
Common Stock Issuance
72.39
+37.79%
52.54
-89.11%
482.45
0.00
Issuance Of Capital Stock
72.39
+37.79%
52.54
-89.11%
482.45
0.00
Net Preferred Stock Issuance
—
—
—
0.00
Preferred Stock Issuance
—
—
—
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category